Chromosome 1q21 abnormalities refine outcome prediction in patients with multiple myeloma - a meta-analysis of 2,596 trial patients

Slični predmeti

• Longitudinal fluorescence in situ hybridization reveals cytogenetic evolution in myeloma relapsing after autologous transplantation
  od: Maximilian Merz, i dr.
  Izdano: (2017-08-01)
• Combining information regarding chromosomal aberrations t(4;14) and del(17p13) with the International Staging System classification allows stratification of myeloma patients undergoing autologous stem cell transplantation
  od: Kai Neben, i dr.
  Izdano: (2010-07-01)
• Prognostic significance of cytogenetic heterogeneity in patients with newly diagnosed multiple myeloma
  od: Maximilian Merz, i dr.
  Izdano: (2018-01-01)
• Peripheral neuropathy associated with subcutaneous or intravenous bortezomib in patients with newly diagnosed myeloma treated within the GMMG MM5 phase III trial
  od: Maximilian Merz, i dr.
  Izdano: (2016-12-01)
• Subcutaneous versus intravenous bortezomib in two different induction therapies for newly diagnosed multiple myeloma: an interim analysis from the prospective GMMG-MM5 trial
  od: Maximilian Merz, i dr.
  Izdano: (2015-07-01)